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INTRODUCTION TO THE HOSPITAL KUALA TRENGGANU 
The state ofTerengganu is located in the East Coast of Peninsular Malaysia, facing the 
South China Sea covering 1 ,295,517 .1 kilometers square. With stretches of white sandy 
beaches along the coast, make Terengganu one of the most popular tourist destinations. 
The main econotnical activities are fisheries and petroleum industry. 
Kuala Terengganu Hospital, which is the only referral hospital for the state, also serves 
7 districts. It is located about 2 kilotneters away from the town of Kuala Terengganu 
and has a total of 786 beds. The hospital is made up of 2 main areas, i.e. the new 8-
storey hospital complex and the old hospital block where both are facing the beautiful 
South China Sea. 
The Obstetric and Gynaecology Department is functioning with 2 consultants, 2 clinical 
specialists, 3 medical officers, 7 posts graduat~ master candidates of University Sains 
Malaysia and University Kebangsaan Malaysia and 12 house officers. There are also 
one tnatron, 4 sisters, 7 8 nurses and 64 support staff. 
MATERNITY COMPLEX (OBSTETRIC SECTION) 
Obstetric section is situated mainly at level 1 and partly at the ground flour and level 2 
of the main building. It includes the clinics, Day care center, Admission center, 
Antenatal ward, Postnatal ward, Labour suites and tnatemity Operation Theatre. 
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There are 4 wards to accotnmodate the obstetric patients, 1 antenatal ward (36 bedded), 
2 postnatal wards (36 bedded-high risk ward and 24 bedded - low risk ward) and 1 first 
class ward ( 10 bedded mixed Obstetric ward). Admission centre served to ensure 
appropriate admission and also minimize delay in clerking. In 1999 the centre received 
13 094 patients. The Bed Occupancy Rate for the antenatal ward is ahnost always 
above 100%. 
The Labour Suite has 12 delivery beds where 3 beds are reserved for patients requiring 
close monitoring during tocolytic therapy or bleeding placenta praevia in which 
expectant management is carried out. Besides that, there is a 2 bedded room for patients 
with severe Pre-eclampsia/ Eclampsia room(PE room). 
This hospital also adopts the 'husband friendly hospital'. The response is good and an 
average of 150 husbands will be with their wives during labour every month. 
Adjoining to the labour suite is the tnatemity theatre where elective and emergency 
Caesarean section are carried out from 8.00 am to 3.00 pm. The services is run by 5 
dedicated maternity staff. 
The Day care service has reduced the number of clinic attendance and wmecessary 
adtnission. In 1999 there were 1466 attendance to the day care centre . There are 3 
antenatal clinic sessions per week i.e. antenatal booking, combined clinic and antenatal 
follow up clinic. There is also 1 postnatal clinic session weekly. The total attendance 
annually is about 10,000. 
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GYNAECOLOGY SECTION 
Gynaecology also contributes to the workload in the Department. Besides having the 
gynaecology clinic, the specialised clinic, Infertility and Intrauterine insemination 
method, oncology, molar and colposcopy are also available. The total attendance for 
the gynae clinic is more than 5000 patients per year. 
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ABSTRAK 
Objectif : Kajian di jalankan untuk menentukan prevalen kes-kes kencing manis 
semasa hamil di kalangan populasi obstetrik Hospital Kuala Trengganu mneggunakan 
kaedah MOGTT membezakan !criteria WHO 1985 dan 1998. Perbandingan komplikasi 
kepada ibu dan bayi juga di ambil kira. Tujuan kedua adalah untuk mengira nilai-nilai 
ramalan keatas cara-cara pengesanan kes kencing manis ketika hamil yang di 
namakan sebagai Glucose Challenge Test (GCT), ciri-ciri potensi untuk mengidap 
kencing man is ketika hamil dan Fasting Plasma Glucose (FPG). Akhir sekali, kajian ini 
bertujuan menentukan prevalen kes kencing manis yang berpanjangan selepas 6 
minggu kelahiran. 
Metodologi : Kajian kohort prospective dan observasi di lalukan antara bulan Julai ke 
November 1999 di Unit Obstetrik, Hospital Kuala Terengganu. Pesakit antenatal di 
bahagi kepada dua kumpulan mengikut kehadiran ciri-ciri potensi menghidap kencing 
manis semasa hamil (iaitu kumpulan berisiko rendah dan tinggi). Ujian GCT di 
jalankan kepada kumpulan berisiko rendah di ikuti dengan ujian MOGTT selepas satu 
atau dua minggu berikutnya. Semua pesakit di dalam kumpulan berisiko tinggi di beri 
tarikh untuk ujian MOGTT. Paras gula > 7.2mmolll di kira sebagai positive untuk 
ujian GCT. Keputusan ujian MOGTT di analisa menggunakan kriteria WHO 1985 dan 
1998. Pesakit yang menghidap kencing manis semasa hamil di rawat mengikut protokol 
yang di sediakan oleh hospital. Mereka di awasi sehingga bersalin atau akan di 
masukkan ke wad pada 38 minggu kehamilan untuk di paksa bersalin. Rekod bayi di 
ambil. Akhirnya mereka di beri tarikh untuk mengulangi ujian MOGTT selepas 6 
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minggu ke/ahiran. Data di ananlisa menggunakan SPSS versi ke-9. Ujian Chi-square 
dan Student t di gunakan untuk mengetahui signifikasi kajian.. Keputusan paras p < 
0.05 di kira sebagai signifikan. 
Keoutusan: Dari 757 wanita, hanya 671 dari mereka dapat melengkapkan kajian. 
Prevalen kes kencing manis semasa hamil ia/ah 9.5%(64 dari 671) menggunakan 
kriteria WH0-1985 dan 10.3%(69 dari 671) menggunakan kriteria WH0-1998. 
Seramai 22 orang dari 199 pesakit berisiko rendah mempunyai keputusan GCTyang 
positive dan sepuluh (6.0%) mengalami kencing manis semasa hamil. Dari 472 pesakit 
di dalam kumpulam berisiko tinggi, 54(11.4%) dari mereka di kesan mengidap kencing 
manis semasa hamil mengikut kriteria WH0-1985 dan 59 (12.5%) mengikut /criteria 
WH0-1998. Tiada perbezaan di dalam data demografic dan komplikasi ke atas ibu dan 
bayi di antara dua /criteria. Pesakit kencing manis semasa hamil di dapati berisiko 
untuk mengalami penyakit tekanan darah tinggi semasa hami/, insiden kelahiran paksa 
dan kaedah kelahiran secara caesarean. Bayi di kalangan mereka di dapati lebih berat 
dan insiden berat bayi melebihi 4 kg adalah signifikan. Tetapi tiada perbezaan di 
dalam kelahiran kurang matang, kecacatan semulajadi, kelahiran mati dan kelahiran 
sangkut bahu. Prevalen kes kencing manis yang berpanjangan se/epas 6 minggu 
kelahiran adalah 26.9% dari kalangan pengidap kemcing manis semasa hamil. Nilai 
sensitiviti bagi kaedah GCT, satu ciri potensi , lebih dari satu ciri potensi untuk 
kencing manis semasa hamil dan FPG adalah 90.0%, 68.8%, 76.2% dan 14.5%. Nilai 
spefisiti bagi ujian yang sama adalah 93.6%, 35.6%, 75.9% dan 100%. Nilai ramalan 
positif adalah 42.8%, 6.0%, 29.6% dan 95%. Nilai ramalan negatif adalah 99.4%, 
100%, 100% dan 91.9%. 
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Kesinwulan: Prevalen kes kencing manis semasa hamil di da/am populasi ini dalah 
setara }ilea di bandingkan dengan ujina-ujian setempat terdahulu. Preva/en 
menggunakan /criteria WH0-1998 di dapati tinggi sedikit berbanding kriteria WH0-
1985. Tetapi tiada perbezaan data demografik, komplikasi ke atas ibu dan bayi di 
antara kedua /criteria melainkan jika di bandingkan dengan ibu-ibu yang tidak 
mangidap kencing manis semasa hamil. Perbezaan yang ketara di lihat untuk cara 
pengesanan kencong manis semasa hamil dan di dapati cara GCT mempunyai nilai-
nilai rama/an yang terbaik secara keseluruhan. Prevalen penyakit kencing manis yang 
berpanjangan 6 minggu selepas ke/ahiran di dapati rendah sedikit jika di bandingkan 
dengan kajian terdahulu mungkin di sebabkan kehadiran yang sangat kurang untuk 
mengulangi ujian MOGTT. 
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ABSTRACT 
Objective: The study is aimed to determine the prevalence, maternal and fotal outcome 
of gestational diabetes mellitus among low and high risk hospital base obstetric 
population using MOGTT WH0-1985 and 1998 criteria. Secondly we aimed to 
determine the predictive value of three different methods of GDM screening (namely 
the GCT, potential diabetic picture and fasting plasma glucose). Lastly, we planned to 
determine the prevalence of persistent diabetes at 6 weeks post-partum among studied 
GDM patients. 
Methodology: A prospective cohort and observational study was conducted from July 
till November 1999 in an Obstetric Unit Hospital Kuala Terengganu. An antenatal 
patient between 22 to 36 weeks gestations were divided into two groups depending on 
presence of clinical risk factors for developing GDM (i.e. low and high risk). GCT was 
performed upon low risk patients followed by MOGTT one to two weeks later. All 
patients in high-risk group were given appointment for MOGTT. GCT of 7.2 mmoll/ or 
more were considered positive. MOGTT results were analysed by using WH0-1985 
and 1998 criteria. Those patients with GDM were managed according to hospital 
protocol. They were followed-up till delivery or admitted at 38 weeks for induction of 
labour. Babies notes were recorded and lastly, those patients with GDM were given 
appointment to repeat MOGTT at 6 weeks post-partum. Data were analysed by SPSS 
version 9. Chi-square and Student t test used to assess the significance. P value of< 
0.05 considered significant. 
Results: Out of 757 women, only 671 completed the study. The prevalence of 
gestational diabetes mellitus in this studied population is 9.5%(64 out of671) by WHO 
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1985 and 10.3% (69 out of671) by WH0-1998 (P value <0.05). There were 199low 
risk patients in which 22 were positive for GCT and 10 of them (6. 0%) were GDM 
Fifty-four (11.4%) out of 472 high-risk patients were GDM using WH0-1985 and 
59(12.5%) by using WH0-1998. Their characteristics are not significantly different. 
GDM patients were significantly associated with PIH, induced labour and increased 
risk of caesarean section. Offspring of GDM tend to be heavier and increased 
incidence to developed macrosomia. No difference in the incidence of premature 
delivery, stillbirth rates congenital abnormality, shoulder dystocia or prenatal 
mortality. The incidence of persistent diabetes 6 weeks post-partum is 26.9% in the 
diabetic picture GDM paitents. The sensitivity for the GCT (Blood sugar > 7.2 mmoVl), 
single risk factor, multiple riskfactors and the FPG are 90.0%, 68.8%, 76.2%, _14.5% 
respectively. The specificity for them is 93.6%, 35.6%, 75.9% and 100% respectively. 
The positive predictive values are 42.8%, 6.0%, 26.9% and 95.0% respectively. The 
negative predictive values are 99. 4%, 100%, 100% and 91.9% respectively. 
Conclusion: The prevalence of gestational diabetes mellitus in this studied population 
is comparable to other local studies. It shows slightly higher when using MOGTI' 
WH0-1998 compared to WH0-1985 criteria. However there is no difference in all 
characteristics and outcome measures unless when compared to non-GDM patients. 
The predictive values of three methods ofGDM screening varied greatly, with the GCT 
being the best overall. Persistent diabetes 6 weeks post-partum were slightly lower to 
comparable study probably because poor turn-up for repeat MOG'IT among previously 
diagnosed as GDM 
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ABBREVIATIONS 
ADA = American Diabetic Association 
AGA - Appropriate Gestational Age 
APH = Antepartum Haemorrhage 
BMI = Body Mass Index 
BW = Birth Weight 
BOH = Bad Obstetric History 
DM = Established Diabetes Mellitus 
FSB = Fresh Still Birth 
FPG - Fasting Plasma Glucose 
GDM = Gestational Diabetes Mellitus 
GCT = Glucose Challenge Test 
HbAIC = Glycosylated Haemoglobin 
IDDM = Insulin Dependent Diabetes Mellitus 
IFG = Impaired Fasting Glucose 
IUD = Intrauterine death 
Kglm2 = Kilogram per meter square 
Kg = Kilogram 
LOA = Large for Gestational Age 
LSCS = Lower Segment Caesarean Section 
MOGTT = Modified Oral Glucose Tolerance Test 
xu 
MMR = Maternal Mortality Rate 
Mmol/1 = milimol per litre 
MSB = Macerated Still Birth 
NIDDM = Non Insulin Diabetes Mellitus 
NDG = National Diabetic Group 
NS = Non Significant 
NPV = Negative predictive value 
POA = Period Of Amenorrhoea 
POG = Period Of Gestation 
PJvfR = Perinatal Mortality Rate 
PE = Pre-Eclampsia 
PPV = Positive pedictive value 
SGA = Small Gestational Age 
Wk = week 
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l.INTRODUCTION TO GESTATIONAL DIABETES MELLITUS. 
Gestational diabetes mellitus (GDM) is defined as any degree of glucose intolerance with 
onset or frrst recognition during pregnancy (Coustan DR et al, 1998). The definition ap-
plies whether insulin or only diet modification is used for treatment and whether or not the 
condition persists after pregnancy. It does not exclude the possibility that unrecognised 
glucose intolerance may have antedated or begun concomitantly with the pregnancy. 
The diagnosis of GDM has implications affecting both the pregnancy and the future health 
of the mother and the fetus. Despite adverse clinical sequelae, there remains ambiguity and 
uncertainty amongst Obstetricians and Physicians on the importance of the screening and 
diagnosing of GDM. Controversy also exists in the management of the pregnancy compli· 
cates by diabetes. 
Although the benefits of careful regulation of maternal glycaemia is well accepted. ques-
h. h trib t t · t · death and congenital tions remain regarding those factors w tc con u e o tntrau enne 
malformations, as well as significant neonatal morbidity observed in the infant of the dia· 
b 
. h Th also debates concerning the need and timing of obstetric interven-
ettc mot er. ere are 
t of foetal well being and maturity. If the preventative health 
tions, including the assessmen 
t b e~ective in reducing the long-term morbidity of GDM, the problems measures are o e 111 
d. .t dt'agnosis and screening need to be addressed. surroun 1ng t s 
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1.1 PREVALENCE OF GESTATIONAL DIABETES MELLITUS 
Approximately 4% of all pregnancies are complicated by GDM, resulting in 135,000 cases 
annually in United States (Franz MJ, 1994). The prevalence may range from 1 to 14% of 
all pregnancies, depending on the population studied and the diagnostic tests employed. 
Compared to white/European women, the prevalence rate for GDM is increased 
approximately eleven folds in women from the Indian subcontinent, eight folds in South 
East Asian women and six and three folds in Arab/Mediterranean and black/ Afro-
Caribbean women, respectively (Dornhorst A et al, 1992). Study done by T.T. Lao et al in 
1998, the prevalence among Chinese and Asian populations using WH0-1985 criteria was 
11%, but 95% of their cases fell into the category of Impaired Glucose Tolerance (lOT) in 
pregnancy. The prevalence of gestational diabetes highly dependent 'on ethnicity. 
Increasing maternal obesity, age and family history of diabetes are additional important 
independent risks for GDM (Shelley-Jones 1993 ). 
In the study done in Kuala Lumpur Hospital by Kamal Bahrin AR et.al (1990), among the 
obstetric population, 500 patients out of 3885 study sample had risk factors for GDM and 
107 (21.4%) had abnormal Glucose Tolerance Test, using WH0-1985 criteria. Seventy 
nine (15.8%) were IGGT and 28(5.6%) had diabetic picture out side pregnancy. Premitha 
et al, 1993 noted 343 (12.7%) out of2690 studied population in University Hospital having 
GDM and 54 (15.5%) of these women did not have any known risk factors. 
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1.2 AETIOLOGY OF GESTATIONAL DIABETES MELLITUS 
From an aetiology perspective, there are three subgroups of gestational diabetes: 
previously undiagnosed abnormal glucose tolerance; pregnancy induced glucose 
intolerance and rarely the early autoimmune beta-cell-destruction phase of insulin-
dependent diabetes mellitus (IDDM). 
After delivery, women in the first group will have impaired glucose tolerance or non-
insulin-dependent diabetes mellitus (NIDDM), those in second group will have normal 
glucose tolerance but has higher risk ofNIDDM in the future. Those in the third group will 
have IDDM, most within two years. 
This clinical spectrum of gestational diabetes is highly dependent on the local prevalence 
of impaired glucose tolerance and NIDDM, and on the other variables such as ethnic 
background, age and basal metabolic (Nelson-Piercy C et al, 1993 ). 
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1.3 PArfiiOPHYSIOLOGY OF GESTATIONAL DIABETES MELLil"US AND ITS 
COMPLICATIONS. 
During normal pregnancy, maternal metabolism adjusts to provide adequate nutrition to 
both the mother and growing fetoplacental unit. Early in pregnancy, glucose homeostasis is 
affected by increases in oestrogen and progesterone, which lead to B cell hyperplasia, and 
increase in insulin secretion. Increase in perip~eral utilisation of glucose result in lower 
maternal fasting glucose levels. Glycogen deposition increase in peripheral tissues, 
accompanied by decrease in hepatic glucose production. Insulin-dependent diabetics 
therefore commonly experience periods of hypoglycaemia in the first trimester. 
Additionally, maternal circulating levels of fatty acids, triglycerides, and ketones are 
increased. Maternal mechanisms to offset this state "accelerated starvation" include 
increased in protein catabolism and accelerated renal gluconeogenesis. 
Lipids become an important maternal fuel as pregnancy advances. In early pregnancy, fat 
storage increases. With the rise of human placental lactogen (hPL), a polypeptide hormone 
produced by syncytiotrophoblast, lypolysis is stimulated in adipose tissue. The release of 
glycerol and fatty acids reduces both maternal glucose and amino acid utilization, and in 
doing so, spares this fuel for the foetus. The action of hPL is responsible, in part, for the 
'diabetogenic state' of pregnancy. In the nonnal pregnant women, glucose homeostasis is 
maintained by an exaggerated rate and the amount of insulin release reaching almost twice 
the non-pregnant level., which later accompanies with decreased sensitivity to insulin and 
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blood glucose are kept within a very narrow range ofbetween 4 and 6 mmoVI during much 
of every 24 hours (Kuhl 1984 ). Other hormones, which appear to modify this response, 
include elevated levels of free cortisol, oestrogen and progesterone (Marest Metal 1995). 
With placental growth, larger amounts of anti-~nsulin factors are synthesized. A women 
with overt diabetes cannot respond to this stress and requires additional insulin 
requirement, approximately 30% to the pre-pregnancy dose, is roughly equivalent to the 
endogenous increase seen in normal gestation (Gillmer M.D.G et al, 1999). 
From 10 to 16 weeks, the fasting level of glucose is significantly lower than the non-
pregnant level and there is a slow but significant rise up to 33 weeks. Thereafter the fasting 
level falls again slowly so that at term it is not significantly different from the non-
pregnant level (Baird 1986). The peak levels of glucose after a carbohydrate load are 
higher than non-pregnant especially after the 20•11 weeks. 
The vast majority of pregnant women manage to maintain their blood glucose within 
normal limit but around 2% cannot do so, and become hyperglycaemic, similarly a further 
2% hypoglycaemic. The consequences of this increasing resistance to insulin activity is 
that eventually, usually late in the second trimester of pregnancy, the capacity for insulin 
secretion is exceeded resulting in impairment of glucose tolerance and gestational diabetic 
in the women so destined. 
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Maternal hyperglycaemia is an important contributor to accelerated foetal growth and the 
development of the large for gestational age infant. The foetal B-cells respond as early as 
11 weeks gestation to maternal hyperglycaemia. Foetal insulin is an anabolic hormone and 
causes visceral enlargement and excess fat deposition in human and experimental animals. 
There is ample evidence that maternal hyperglycaemia and the resulting foetal hyperinsu-
linaemia have a permissive effect on the foetal growth patterns, with the greatest influence 
being seen between 28 and 32 weeks. This anabolic effect also influenced by the genetic 
factor, with certain ethnic groups being more susceptible to the growth promoting effects 
of hyperglycaemia. More importantly, maternal factors including age, body weight and 
parity independently contribute to increasing birth weight (Dornhorst A et al, 1998). 
Studies of chronic hyperglycaemia in pregnant sheep have shown increased aerobic and 
anaerobic glucose metabolism causing increased oxygen consumption, lactate production 
and fall in pH and oxygen tension. Three changes are thought to be the most likely the 
causes of the sudden foetal death that may occur late in diabetic pregnancy. Analyses of 
human umbilical cord blood have confirmed significant associations between maternal 
blood glucose and foetal insulin concentrations and the degree of foetal acidemia. In addi-
tion the combination of foetal hyperinsulinaemia and foetal hypoxia appears to stimulate 
' 
both foetal medullar and extramedullary erythropoiesis causing polycythaemia possibly as 
a result of increased foetal erythropoeitin levels. 
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Foetal hyperinsulinaemia also predisposes to a variety of effects observed in the neonate 
hypo glycaemia, respiratory distress syndrome and jaundice. These latter two complications 
appear to be due to inhibition of the effect of cortisol on the enzyme systems concerned 
with the surfactant production by the foetal lungs and the development of microsomal en-
zyme systems within the foetal liver. 
Several obstetric problems occur more commonly in diabetic pregnancy, their frequency 
being directly related to the quality of the diabetic control achieved. The most common 
feature of poorly controlled diabetes is polyhydramnios, which can occur due to a foetal 
osmotic diuresis induced by matemofetal hyperglycaemia. Besides that they are also prone 
to get infections especially urinary and genital tract infection particularly candidiasis. Pre-
mature contraction occurs in up to 20% of diabetic pregnancies and may occasionally be 
associated with polyhydramnios and infections. Pre-eclampsia occurs approximately twice 
as frequently in diabetic as non-diabetic pregnancies. Serial serum creatinine and urate 
concentrations and 24 hour urine protein measurements provide early biochemical evi-
dence of proteinuric pre-eclampsia and also help to differentiate between pregnancy in-
duced hypertension and pre-existing hypertension masked by pregnancy. 
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1.4 SCREEENING OF GDM, DOES IT IMPROVE MATERNAL AND 
PERINATAL OUTCOME? 
Screening for gestational diabetes remains extremely controversial. There is much debate 
worldwide as to whether women should be screened for GDM at all, only high-risk women 
should be screened, or universal screening for all pregnant women should be the standard 
for care. 
The short term benefits of screening and treating gestational diabetes have focused on preg-
nancy outcome. In high-risk populations, with a high background prevalence of diabetes 
combined with limited access to medical and perinatal care, perinatal mortality can be seen to 
improve after screening for and treatment of gestational diabetes. Retrospective studies sug-
gest a benefit on stillbirth rates after the introduction of screening and treating gestational 
diabetes in low risk populations, but demonstrating a benefit on perinatal mortality in pro-
spective trials has proved to be more difficult. In Western populations, with a low prevalence 
of diabetes, good access to medical care, and low perinatal mortality and morbidity rates, 
there are ethical constraints in mounting randomised trials with sufficient power to test 
whether treating gestational diabetes reduces perinatal morbidity. Prospective studies in these 
populations have therefore assessed pregnancy outcome using surrogate markers of diabetic 
control. These include macrosomia, need for caesarean section and fetal hypoglycaemia. None 
of these end points are specific for diabetes and many are influenced by the practice of indi-
vidual obstetricians, maternal obesity, age, and parity. 
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Much confusion in terms of who should be screened, how to screen, and the management 
of those with positive results. Confusion arises from lack of or poor quality evidence, 
compounded in this instance by a concept that gestational diabetes mellitus found on risk 
of subsequent non-insulin dependent diabetes mellitus rather than outcome of the index 
pregnancy. In addition, the criteria for gestational diabetes prescribe a minimum, but not a 
tnaximum, level of glucose intolerance, so that any group of women labelled as having 
gestational diabetes might contain some with glycaemia in the range that qualifies for a 
diagnosis of non-insulin dependent diabetes, rendering comparisons of different series 
in1possible. R J Jarrett et al (1997) suggested four questions, which required answers to 
achieve resolution: How severe must maternal hyperglycaemia be to measurably worsen 
pregnancy outcome? Can we intervene to prevent adverse outcomes? Is such intervention 
cost effective? If so, what is the most appropriate way of screening and detecting the 
problem? (R J Jarrett et al, 1997). 
Opponents of screening argue that it incurs significant financial costs and stressful burden 
on healthcare institutions, society and women, without usefully altering the prenatal 
outcome. The diagnostic label of GDM sensitises obstetricians, thereby increasing the 
number of interventions and caesarean delivery even though the weight of the baby is 
appropriate-for gestational-age infants. 
Proponents of screening argue that the primary benefit lies in the early identification of 
women at risk for developing type 2 diabetes mellitus. Early identification may help 
modify the natural history of type 2 diabetes mellitus and thus prevent diabetic 
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complications. The focus has now shifted to the perinatal risks associated with GDM rather 
than the long-term effects. Many retrospective and prospective studies have suggested 
convincingly that there is an association between carbohydrate intolerance and perinatal 
complications, in particular foetal macrosomia and resultant shoulder dystocia and 
caesarean delivery. 
Those who do not favour screening for gestational diabetes claim, among other things, that 
the current screening and diagnostic strategies are cumbersome. In this issue Perucchini et 
al ( 1999), propose a protocol, which could counter this argument: they suggest using a 
fasting glucose value as a screen for gestational diabetes. This protocol differs from the 
two currently recommended procedures. 
Attempts to detect unrecognised diabetes in pregnancy are a part of established practice in 
every antenatal clinic in this country. The justification for this is the possible increased in 
risk of perinatal death amongst women who have an abnormal GTT in pregnancy. The 
success of these efforts varied widely because of the generalised lack of any consistent and 
systemic approach to the problem. If screening is to be effective it must be comprehensive, 
needs to reflect the ethnicity of the population, the availability of health care, and the 
econotnic and medicolegal expectations of the country. Once the decision has been made 
to screen, a reproducible screening test needs to be chosen that is sensitive, specific and 
easily applied. Many screening systems have been advocated but a few are worthy of 
consideration for the reasons given above. 
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1.4.1 ORAL GLUCOSE CHALLENGE TEST 
The most universally researched screening test is the O'Sullivan test, which involves 
One-hour time blood glucose sample after a 50 g Oral glucose load. Soarse et al in 
1997, stated the overall sensitivity was 95o/o and specificity 85% for detecting pregnancy 
induced glucose intolerance that occurred at 20-28 weeks gestation. 
A first trimester test is advisable in high-risk patient, in which more women will have 
GDM before 20 weeks. A cut off value of7.8 nunol/1 is most commonly used. If this level 
is used, approximately 14% of the population will require an OGTT and the diagnosis of 
GDM will be missed in approximately 1 Oo/o of the affected population (Coustan et al, 
1989). If a cut off value of 7.2 mmoVl were used, virtually all cases all GDM would be 
identified, but 23% of the pregnant population will require an OGTT (Coustan et al, 1990). 
A cut off value of 7.8 mmoVI yielded a sensitivity of 59% and a specificity of 91% (Table 
1.4.1 ). A cut off value of 7.5 mmoVl, as used by several investigators, yielded a sensitivity 
of 61% and specificity of 88%. The best cut of! value for the 50 g screening test in Soarse 
et all, 1997, was 7.2 mmolJl (sensitivity 68%, specificity 82%). Thirty eight per cent of the 
women reported food intake up to 1 hour before the challenge test, 32% (167) between 1 
and 2 hours before, and 27% (141) >2 hours before~ 13 women did not report the time of 
last food intake. Analysis of the data for the women with food intake> 2 hours before the 
challenge test suggested that the sensitivity of the 
11 
1.4.2 FASTING PLASMA GLUCOSE 
It has been recently compared with other measures of hyperglycaemia, and was found to be 
the best single test for diagnosing diabetes because its simplicity, low cost, reproducibility, 
and world wide availability. Its has been recently recommended as the most important di-
agnostic tool for the diabetes in non pregnant adult (ADA, 1997; WHO, 1998). 
In this recommendation, the cut off point for the diagnosis of diabetes with fasting plasma 
glucose has been lowered to 7.0 mmoVI. If this cut point were to be applied to pregnancy, 
fasting glucose could serve as screening and a diagnostic tool, a strategy that could poten-
tially improve early diagnosis at a lower cost. 
Combining fasting blood glucose with potential diabetic picture has been found to have 
sensitivity of 90 % but the specificity of about 50%. However, that the diagnosis of gesta-
tional diabetes with fasting plasma glucose still awaits validation against obstetric outcome. 
Other screening test, include random glucose values, glucosuria, fructosamine, diurnal glu-
cose profiles, and glucose responses to mixed meals have been less extensively evaluated 
in pregnancy than the O'Sullivan test, which remains the gold standard. The sensitivity of 
purely clinical risk factors is poor, <70%, especially in multiethnic populations, since they 
do not include ethnicity. 
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1.4.3. POTENTIAL DIABETIC FEATURES 
The commonest approach to screening for gestational diabetes has been to perfonn glucose 
tolerance test on women with defined potential diabetic features ( i.e. clinical history aand 
current problems during pregnancy). On one hand this may result in 37% of the population 
requiring glucose tolerance test as approximately one in three antenatal patients has 
potential features of diabetes in her history, or. the other chemical diabetes may arise in 
women without potential diabetic features (O'Sullivan et al 1973). 
This method has a false-negative rate of about one-third (O'Sullivan et al. 1973, Gillmer et 
al. 1980). Furthermore, the potential diabetic features is equally distributed in the normal 
and abnormal glucose tolerance population. Reed (1984) estimated that 20% of the patients 
with gestational diabetes will be missed with this original method. Carpenter and Coustan 
(1982) modified the method by lowering the test threshold at the expense of test 
specificity. 
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1.5 STANDARD REFERENCE TESTS FOR GESTATIONAL DIABETES MELLITUS 
Commonly accepted diagnostic criteria for diabetes mellitus were developed by the 
National Diabetes Data Group (NDDG) in 1979 (Diabetes 1979) and the World Health 
Organisation (WHO) in 1980 and updated in 1985 (WHO Tech Rep Ser 1980 & 1985) 
(Table 2). During it annual meeting in 1997, the American Diabetes Association (ADA) 
approved new diagnostic criteria for diabetes mellitus. On the basis of data from three 
different populations the intention was to identify the fasting blood glucose concentration 
that best predicted the risk developing microvascular complications. The revised criteria 
are symptoms of diabetes and a random plasma glucose concentration > 11.1 mmol/1 or a 
fasting plasma glucose > 7.0mmolll or 2 hour plasma glucose > 11.1 mmol/1 during a 
standard 75 g oral glucose tolerance test, as previously recommended by ADA and NDDG, 
approved by WHO (DECODE Study- Wareharm and O'Rahilly et al, 2000). 
The main changes are the diagnostic fasting plasma (blood) glucose value has been 
lowered to > 7.0 mmol /1. A new category of Impaired Fasting Glycaemia (IFG) is 
proposed to encompass values which are above normal but below the diagnostic cut-off for 
diabetes (plasma > 6.1 to <7.0 mmol/1; for the whole blood > or =5.6 to <6.1 mmol/1 
(Peter G Colman et al, 1999). 
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Table 1.5 The Recommendations of diagnostic. criteria for Diabetes Mellitus by WHO 
and ADA. 
Diagnostic criteria WHO 1985 WHO 1998 NDDG-100 g NDDG-75 g 
(mmoVl) Glucose load Glucose load 
(Annex 2) (Annex 3) (Annex 4) 
DM 










Oh <7.8 <7.0 - -
2h 7.8-11.0 7.8-11.0 - -
IFG 
- 6.1-6.9 - -
This changes are based primarily on cross-sectional studies demonstrating the presence of 
microvascular ( McCance DR et al, 1994) and macro vascular complications at these lower 
glucose concentrations ( Charles MA et al,Lancet 1996). In addition, the 1985 WHO diag-
nostic criteria for diabetes based on fasting plasma level of> 7.8 mmoVl represents a 
greater degree ofhyperglycaemia than the criteria based on plasma glucose level two hours 
after a 75 g glucose load of> 11.1 mmol/1 (Finch CF et al, 1990). A fasting plasma glucose 
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level of >7 mmol/1 accords more closely with this 2 hour post-glucose level. 
Epidemiological data from 20 European studies found that fasting plasma glucose of 7.0 
mmol/1 or more, predicted a diabetic 2 hour-plasma glucose with a sensitivity of 49.0% 
and specificity of98.2% (DECODE Study, 1999). 
Previously, the oral glucose test (OGTT) was recommended in people with a fasting 
plasma glucose level of 5.5-7.7 mmol/1 or random plasma glucose level of 7.8-11.0 
mmoVI. After a 75 g glucose load, those with a 2 hour plasma glucose level of< 7.8 
mmol/1 were classified as nonnoglycaemic, of7.8-11.0 mmol/1 as having impaired glucose 
tolerance and of> 11.1 mmol/1 as having diabetes. 
The new diagnostic criteria proposed by the ADA and WHO differ in their 
recommendation on use of the oral glucose tolerance test (OGTT). The ADA makes a 
strong recommendation that fasting plasma glucose level can be used on its own and that, 
in general, the OGTT need not be used (Diabetic Care, 1997). The WHO group argues 
strongly for the retention of the OGTT and suggests using fasting plasma glucose level 
alone only when circumstances prevent the performance of the OGTT. There are concerns 
that many people with fasting plasma glucose level< 7.0 mmol/1 will have manifested 
abnormal result on the OGTT and are at risk of microvascular and macrovascular 
complications (Peter Gcolman et al, April 1999). 
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The conformational diagnostic test for gestational diabetes remains controversial. Glucose 
tolerance in pregnancy is a continuum; with no universally accepted criteria for defining 
the level at which glucose intolerance becomes. abnormal and can be classified as GDM 
(Keen H, 1990). The lack of consensus for diagnosing GDM, has resulted in the WHO 
proposing the same diagnostic criteria be used for GDM as those for impaired glucose 
tolerance outside pregnancy, namely a 2 hours plasma glucose value greater than 7.8 
mmol/1 on the 75 g OGTT. Meaning that, pregnant women who meet WHO criteria for 
diabetes mellitus, or impaired glucose tolerance (IGT) are classified as having Gestational 
Diabetes Mellitus (GDM). 
In the study by J.S.D. Nicholls et al, in 1995, showed that women who have GDM 
identified by WHO criteria have significant impairment of insulin release in respond to 
oral glucose tolerance test. He found that the WHO identifies women with a level of 
glucose intolerance, which is associated with a blunted and attenuated insulin response to 
oral glucose. Normal pregnancy requires that insulin release increase to counteract the 
physiological fall occurring in maternal insulin sensitivity. He suggest that it is the 
inability to adequately increase insulin secretion that is the cause of glucose intolerance of 
GDM, rather than a greater than expected fall in pregnancy related insulin sensitivity. The 
WHO criteria of GDM therefore identify women similar metabolic characteristics as 
described using the 100 g OGTT and the American National Diabetic Data Group (NDDG) 
criteria. In WHO new criteria ( 1998), defined GDM as the joint category of diabetes ( 
fasting plasma glucose > 7.0 mmol/1 or 2 hours glucose > 11.0 mmol/1) and impaired 
glucose tolerance (IGT) (2 hours glucose> 7.8 mmol/1) first detected in pregnancy (Alberti 
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KGMM et al, 1998). Compared to previous recommendations, the fasting glucose cut-
point has been lowered from 7.8 mmoVI to 7.0 mmol/1. However, its significance in 
pregnancy outcomes needs further evaluation. M.I. Schmidt et al (2000) described, of the 
5004 pregnant women who completed an OGTT, 379 (7.6%) had GDM by 1998 criteria. 
Of these 379 cases, only 21 (5.5 %) had hyperglycaemia in the range considered diabetes 
mellitus outside pregnancy; the remaining 358 (94.5%) had IGT. Using the 1985 criteria, 
378 cases ofGDM were found, 15 in the diabetes range and 363 in the IGT. He concluded 
that the prevalence of GDM is minimally altered by the new WHO definition. Although 
GDM is a common condition, the vast majority of the cases have hyperglycaemia in the 
range considered impaired glucose tolerance outside pregnancy. 
After the pregnancy ends, the women should be reclassified as having either diabetes 
mellitus, or IGT, or normal glucose tolerance based on the result of a 75 g OGTT six 
weeks or more after delivery. It should be emphasized that such women, regardless of the 
six-week post-pregnancy result, are at increased risk of subsequently developing diabetes. 
The significance of IFG by WHO new criteria in pregnancy remains to be established. Any 
women with IFG, however, should have a 75 g OGTT (K.G.M.M. Alberti et at, 1998). 
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1.6 CLINICAL PRACTICE RECOMMENDATIONS 2000 PRODUCED BY 
AMERICAN DIABETES ASSOCIATION: VOLUME 23 SUPPLEMENT 1 
Risk assessment for G·DM should be undertaken at the first prenatal visit. Women with 
clinical characteristics consistent with a high risk of GDM: 
l.Marked obesity (BMI> 30kg/m2) 
2.Personal history of GDM 
3.Glycosuria, 
4.Strong family history of diabetes 
should undergo glucose testing as soon as feasible. If they are found not to have GDM at 
that initial screening, they should be retested between 24 and 28 weeks of gestation. 
Women of average risk should have testing undertaken at 24-28 weeks of gestation. Low-
risk status requires no glucose testing, but this category is limited to those women meeting 
all of the following characteristics: 
1. Age < 25 years 
2. Weight normal before pregnancy 
3. Member of an ethnic group with a low prevalence of GDM 
4. Not known diabetes in first-degree relatives 
5. No history of abnormal glucose tolerance 
6. No history of poor obstetric outcome. 
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A fasting plasma glucose level> 126 mg/dl (7.0 mmol/1) or a random plasma glucose >200 
mg/dl (ILl mmol/1) meets the threshold for the diagnosis of diabetes, if confirmed on a 
subsequent day, and precludes the need for any glucose challenge. In the absence of this 
degree of hyperglycaemia, evaluation for GDM in women with average or high-risk 
characteristics should follow one of two approaches: 
1.6.1 One-step approach: 
Perform a diagnostic oral glucose tolerance test (OGTT) without prior plasma or serum 
glucose screening. The one-step approach may be cost-effective in high-risk patients or 
populations (e.g., some Native-American groups). 
1.6.2 Two-step approach: 
Perform an initial screening by measwing the plasma or serum glucose concentration 1 
hour after a 50-g oral glucose load (glucose challenge test [OCT]) and perform a diagnostic 
OGTT on that subset of women exceeding the glucose threshold value on the OCT. 
When the two-step approach is employed, a glucose threshold value >140 mg/dl (7.8 
mmol/1) identifies approximately 80% of women with GDM, and the yield is further 
increased to 90% by using a cut-off of> 130 mg/dl (7.2 mmol/1). 
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With either approach, the diagnosis of GDM is based on an OGTT. Diagnostic criteria for 
the I 00-g OGTT are derived from the original work of O'Sullivan and Mahan, modified by 
Carpenter and Coustan (Annex 3), and are shown in Table 1.5. Alternatively, the diagnosis 
can be made using a 75-g glucose load and the glucose threshold values listed for fasting, 
1 h, and 2 h; however, this test is not as well validated as the 100-g OGTT. 
1.7 TREATMENT OF GESTATIOANL DIABETES MELLITUS 
Women with gestational diabetes have two metabolic characteristic) impaired s .. cell 
recognition of elevated glucose concentration, and ii) a delay in release of insulin. There 
are two treatment options: i) dietary treatment or ii) insulin treatment when dietary 
treatment alone is inadequate. 
In normal weight GDM women, residual beta cell function is present and their problem is 
insufficient insulin reserve capacity to maintain nonnoglycaemia with meal stimulation. It 
is thereby physiological to give them a small dose of rapid-acting insulin before each meal. 
In obese GDM women, the problem is different. In addition to the defects in beta cell 
function, they may have appreciable insulin resistance secondary to obesity that becomes 
more intense during pregnancy. They respond well to a reduction in caloric intake and 
pre prandial doses of rapid-acting insulin. 
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Once the diagnosis of GDM is established, patients are begun on dietary program of 2000-
2500 calories daily with the exclusion of simple carbohydrates (Hollingsworth 1992). 
Obese women with GDM may be managed on as little as 1200-1800 kcaVday with less 
weight gain and no apparent reduction in fetal size. 
Tight maternal serum glucose control during 20th to 30th weeks of gestation can decrease 
the incidence of fetal macrosomia, however, good glycaemic control during the third 
trimester may not have similar effect (Langer 1989). Gestational diabetes may be safely 
followed until 40 weeks as long as the fasting and postprandial glucose values remain 
normal (Landon 1994 ). 
1.7.1 ANTENATAL ASSESSMENT OF THE FETUS 
Accurate information about the duration of pregnancy, fetal growth and fetal well being 
remains important. Ultrasound use in diabetic pregnancy is to measure the crown-rump 
length to confirm the duration of pregnancy. A biparietal diameter measurement should 
also be performed in the mid-trimester, ideally at 16 weeks gestation, to provide additional 
information about gestational age. Blood for serum alpha fetaprotein can also be taken at 
this gestation both to screen for neural tube defect and as part of "triple test" used to 
screen for Down syndrome. 
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A detail fetal examination to exclude congenital anomalies especially of neural, cardiac, 
renal system should be performed between 18 to 20 weeks, so that termination of the 
pregnancy can be considered, if appropriate. Serial growth based on measurements of the 
fetal head and abdominal circumference provide best means of identifying those fetus 
becoming macrosomic. 
The non-stress test appears to be the preferred antepartum heart rate screening test in the 
management of patients with gestational diabetes (Landon 1990). In patients with poor 
control, in whom the incidence of abnormal test and intrauterine death is greater, testing is 
performed earlier in gestation and more frequent. 
Biophysical profile did not appear to add more information about fetal condition if the 
non-stress test result was reactive, but a score of 8 based on ultrasound parameters was as 
reliable in predicting good fetal outcome as was a reactive non-stress test (Golde 1984 ). 
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